SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Laserscope (NASDAQ LSCP)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Daniel Kahn who wrote (78)8/21/1997 12:24:00 AM
From: Richard Haugland   of 314
 
I sold out Monday and today (too low of course on Monday but at 6 1/4 today). Mostly happy to get my money back, although if Photofrin gets approval (apparently in September) one can expect another jump that may be even bigger because apparently LSCP's laser was included in the FDA application. Photofrin has been round for probably 12 years at least and rights were formerly owned by Johnson and Johnson, among others. I see it is now approved for espohagal cancer treatment.

I may look to get back in after the current trend subsides. However I rarely buy a stock back at a price higher than I sold it.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News